Back to search

France· FR:68559206

LERCANIDIPINE BIOGARAN 10 mg, comprimé pelliculé sécable

A lercanidipine product containing chlorhydrate de lercanidipine, registered in France by BIOGARAN, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C08CA13

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLERCANIDIPINE BIOGARAN 10 mg, comprim…ATCC08CA13REGISTER NO.FR:68559206PACKS LISTED3CHECKEDSeptember 12, 2026

Where it is registered

Lercanidipine is registered in 16 of 19 countries.

Countries holding a registration under ATC C08CA13 (lercanidipine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Lercanidipine · ATC C08CA13

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lercanidipine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.14 in France to $0.36 in Switzerland — a ×2.6 gap.

  • France: $0.14 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Lercanidipine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.36
  • ES Spain$0.25
  • IT Italy$0.21
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE LERCANIDIPINE
Manufacturer
BIOGARAN
Country
France (FR)
ATC code
C08CA13
ATC class
Lercanidipine
Defined daily dose
10 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 3

3 priced
  • cip13
    3400930192139
    flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant
    EUR 4.79
  • cip13
    3400939158006
    plaquette(s) PVC-Aluminium de 30 comprimé(s)
    EUR 4.79
  • cip13
    3400939158464
    plaquette(s) PVC-Aluminium de 90 comprimé(s)
    EUR 14.19

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for lercanidipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lercanidipine · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lercanidipine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lercanidipine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Lercanidipin Accord, Lercanidipin Actavis
  • Belgium · Lercanidipin Sandoz, Lercanidipine Ab
  • Bulgaria · Areta, Арета
  • Cyprus · Zanedip
  • Czechia · Jospiten, Kapidin
  • Germany · Carmen, Corifeo
  • Denmark · Lercanidipine, Lercanidipine Accord
  • Estonia · Lercanidipine Accord, Lercanidipine Actavis
  • Spain · Lercadip, Lercanidipino Aurovitas Spain
  • Finland · Lercamed, Lercanidipin Hydrochlorid Actavis
  • United Kingdom (Northern Ireland) · Lercanidipine Generics [uk], Lercanidipine Hcl Recordati Industria Chimica E Farmaceutica S.P.A.
  • Greece · Lercadip, Zanidip
  • Croatia · Lercanil, Pinox
  • Hungary · Kapidin, Lecalpin
  • Ireland · Lecalpin, Lercanidipine Clonmel
  • Iceland · Lercanidipin Actavis, Lerkanidipin Actavis
  • Italy · Cardiovasc, Lercadip
  • Lithuania · Lercanidipine Actavis, Lercanidipine Ingen Pharma
  • Luxembourg · Lercanidipine Eg, Zanidip
  • Latvia · Kapidin, Lercanidipine Accord
  • Malta · Lercanidipine Torrent
  • Netherlands · Lercanidipine Accord, Lercanidipine Hcl Amarox
  • Norway · Lercanidipine Accord, Lercanidipine Orion
  • Poland · Jospiten, Kapizen
  • Portugal · Lercanidipina Alter, Lercanidipina Atral
  • Romania · Lercanidipină Gemax Pharma, Leridip
  • Sweden · Lercamed, Lercanidipine Accord
  • Slovenia · Lecalpin, Lercapress
  • Slovakia · Kapidin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e26b77ba-6740-4ce0-b3a6-af9133726f1f
GET /v1/drugs/e26b77ba-6740-4ce0-b3a6-af9133726f1f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68559206",
  "date_amm": "2009-01-29",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE LERCANIDIPINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about lercanidipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.